Daltontx
AI drug discovery platform for pharmaceutical, biotech and CRO discovery teams
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-07
About Daltontx
DaltonTx develops Dalton, a platform that connects project data, computational tools, AI agents and experimental results to support drug-discovery decisions. Its workflows cover small molecules and biologics, including molecule design, candidate prioritisation and learning from experimental results.
The company sells to pharma, biotech and contract research organisation (CRO) teams running discovery programmes. It is based in London and was founded in 2024. DaltonTx raised a £4 million seed round and lists backing from Redalpine, IQ Capital and Seedcamp.
Product: Dalton, an AI-powered drug discovery platform for managing data, computational workflows, candidate design and experimental learning.
Jobs at Daltontx
More biotech & pharma companies
Daresbury Proteins
Mammalian recombinant protein production and cell line development for academic and industry research partnersNew on EvolcDloc Biosystems
Organ-on-chip systems and preclinical drug-testing services for pharmaceutical and biomedical research teamsYoung companyNew on EvolcDna Worldwide Group Holdings
DNA testing and related forensic services for individuals, families, immigration applicants and legal casesYoung companyNew on EvolcDnae Group Holdings
Point-of-need semiconductor DNA sequencing diagnostics for infection testing in hospital settings, developed in LondonNew on EvolcDodrotu
Physics-based molecular discovery workflows and datasets for drug developers targeting oncology and infectious diseasesNew on EvolcDomainex
Integrated drug discovery CRO running hit identification to lead optimisation for biotech and pharma clientsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- FastlyHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-served-by
- Response headerx-served-by
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
